Group 1 - The core viewpoint of the news is that Wanxing Technology has launched an "AI Video Large Model Laboratory" in collaboration with Huawei Cloud, aiming to explore innovations in large models and the deep application of AI in digital creative scenarios [1] - Wanxing Technology has been actively collaborating with leading companies both domestically and internationally, including Intel, NVIDIA, Universal Music, and Dolby Laboratories, enhancing its technological capabilities and market presence [1] - The recognition from major industry players like Huawei and NVIDIA is attributed to the company's accumulated strength and continuous investment in talent [1] Group 2 - Wanxing Technology has initiated a campus recruitment plan targeting undergraduate and master's students for the 2026 graduation year, offering positions in various fields with competitive salaries, including a first-year salary of up to 1 million yuan for some roles [2] - The company has upgraded its internship recruitment plan, providing daily wages of up to 1,000 yuan and a pathway for outstanding interns to secure full-time positions [2] - As a leading player in the digital creative software sector in China, Wanxing Technology has over 1.5 billion global users and a diverse product matrix covering video, image, drawing, and document creative software [2]

Group 1: Tencent's Financial Performance - Tencent's international gaming revenue increased by 23% year-on-year to 16.6 billion yuan in Q1 2025, marking a record high for three consecutive quarters, driven by strong performances from PUBG MOBILE and Supercell games [1] - Domestic gaming revenue reached 42.9 billion yuan, a 24% year-on-year increase, attributed to revenue growth from Honor of Kings and Peacekeeper Elite, along with contributions from newly released games [1] Group 2: WeChat's E-commerce Initiatives - Tencent announced the establishment of an e-commerce product department to explore new transaction models within WeChat, aiming to accelerate the development of transaction infrastructure and ecosystem [2] Group 3: GlaxoSmithKline's Acquisition - GlaxoSmithKline has agreed to acquire Boston Pharmaceuticals' subsidiary BP Asset IX for up to $2 billion to gain rights to Efimosfermin, a drug in Phase III clinical trials for treating fatty liver disease, with an upfront payment of $1.2 billion and potential milestone payments of up to $800 million [3] Group 4: Investment and Financing Activities - Carl Power completed nearly 300 million yuan in financing to advance the commercialization of L4 autonomous freight delivery, with operations expanding across seven cities and 20 clients [4] - Zhejiang Junliang Supply Chain Technology Service Co., Ltd. secured 10 million yuan in angel round financing to enhance its digital risk control system and supply chain financial services platform [6]